US Stock MarketDetailed Quotes

EVOK Evoke Pharma

Watchlist
  • 3.6236
  • -1.0364-22.24%
Close Mar 3 16:00 ET
5.38MMarket Cap-0.36P/E (TTM)

About Evoke Pharma Company

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It also develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.

Company Profile

SymbolEVOK
Company NameEvoke Pharma
Listing DateSep 25, 2013
Issue Price12.00
Founded2007
CEOMr. Matthew J. D'Onofrio
MarketNASDAQ
Employees4
Fiscal Year Ends12-31
Address420 Stevens Avenue,Suite 370
CitySolana Beach
ProvinceCalifornia
CountryUnited States of America
Zip Code92075-2074
Phone1-858-345-1494

Company Executives

  • Name
  • Position
  • Salary
  • Matthew J. D'Onofrio
  • Chief Executive Officer, Director, Principal Accounting Officer, President, Chief Operating Officer, Secretary and Treasurer
  • 857.37K
  • Dr. Marilyn R. Carlson, D.M.D.,M.D.
  • Chief Medical Officer
  • 728.49K
  • Mark A. Kowieski
  • Chief Financial Officer
  • --
  • Cam L. Garner
  • Chairman of the Board
  • 102.95K
  • Benjamin Smeal
  • Independent Director
  • --
  • Vickie W. Reed
  • Independent Director
  • 85.31K
  • Kenneth J. Widder, M.D.
  • Independent Director
  • 77.54K
  • Dr. Todd C. Brady, M.D.,PhD
  • Independent Director
  • 79.43K
  • Greg Pyszczymuka
  • Independent Director
  • --
  • Malcolm R. Hill, Pharm.D.
  • Independent Director
  • 79.18K

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More